Find a Clinical Trial
Filter
A Phase 3 Study of Sotatercept in Participants with PAH WHO FC III or FC IV at High Risk of Mortality
Pulmonary hypertension
All genders
18-75
Recruiting now
Department of Medicine, Division of Pulmonary, Critical Care + Sleep Medicine
Keros PAH Study
Pulmonary arterial hypertension (PAH)
All genders
18-100
Recruiting now
Department of Medicine, Division of Pulmonary, Critical Care + Sleep Medicine
A Long-term Follow-up Study of Sotatercept for PAH Treatment
Pulmonary hypertension
All genders
18+
Recruiting now
Department of Medicine, Division of Pulmonary, Critical Care + Sleep Medicine
Remodel-2
Multiple sclerosis
All genders
18-55
Recruiting now
Department of Neurology